Literature DB >> 26394513

[Methylphenidate].

Hirokuni Tagaya, Norio Murayama, Yuko Fukase.   

Abstract

Methylphenidate enhances dopaminergic neurotransmission in the central nervous system. Methylphenidate improves social functions as well as clinical symptoms of patients suffered of narcolepsy and attention deficit hyperactivity disorder (ADHD), though it has the potential of abuse. It is reported that approximately 4% of older teens and emerging adults in the US annually misusing methylphenidate. Non-medical/illegal use of methylphenidate causes many consequences including addiction, negative reactions and medical complications. Growing number of illegal trades of methylphenidate and medical complications caused by misuse of methylphenidate urged Japanese government to introduce regulations limiting access to prescribed methylphenidate in 2008. Clinicians should be cautious about prescribing methylphenidate, especially patients with complaint of excessive daytime sleepiness.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26394513

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  1 in total

1.  Medications for attention-deficit/hyperactivity disorder in Japan: A retrospective cohort study of label compliance.

Authors:  Daniel Fife; Erica A Voss; Jill Hardin; Hany Rofael; Ira D Solomon; Patrick B Ryan; Paul Stang
Journal:  Neuropsychopharmacol Rep       Date:  2021-06-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.